Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.hrtlng.2020.08.012 http://scihub22266oqcxt.onion/10.1016/j.hrtlng.2020.08.012 32861886!7440278!32861886     free     free     free       Heart+Lung 2020 ; 49 (6): 688-691 Nephropedia Template TP {{tp|p=32861886|t=2020. Management of COVID-19 in a durable left ventricular assist device recipient: A continuity of care perspective |pdf=|usr=}}{{32861886}} gab.com Text Management of COVID-19 in a durable left ventricular assist device recipient: A continuity of care perspective JO: Heart Lung http://www.kidney.de/pget.php?&tw=1&pmid=32861886 #FOAvip COVID-19 is impacting the cardiovascular community both here in the United States and globally. The rapidly emerging cardiac complications have heightened implications for those with underlying cardiovascular disease. We describe an early case of COVID-19 in a left ventricular assist device recipient in the United States. We discuss our clinical management during the initial admission, outpatient management, and a unique complication of this disease over a 40-day disease course. Twit Text FOAVip Management of COVID-19 in a durable left ventricular assist device recipient: A continuity of care perspective ????Heart Lung http://www.kidney.de/pget.php?&tw=1&pmid=32861886 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32861886 #FOAvip English Wikipedia <ref>{{Cite pmid|32861886}}</ref> Management of COVID-19 in a durable left ventricular assist device recipient: A continuity of care perspective #MMPMID32861886 Korada SKC; Mann JA; Hasan AK; Baliga RR; Mokadam NA; Benza RL; Vallakati A Heart Lung 2020[Nov]; 49 (6): 688-691 PMID32861886show ga COVID-19 is impacting the cardiovascular community both here in the United States and globally. The rapidly emerging cardiac complications have heightened implications for those with underlying cardiovascular disease. We describe an early case of COVID-19 in a left ventricular assist device recipient in the United States. We discuss our clinical management during the initial admission, outpatient management, and a unique complication of this disease over a 40-day disease course. |*Coronavirus Infections/diagnosis/physiopathology/therapy[MESH] |*Heart-Assist Devices[MESH] |*Pandemics[MESH] |*Pneumonia, Viral/diagnosis/physiopathology/therapy[MESH] |Betacoronavirus[MESH] |Blood Pressure/physiology[MESH] |COVID-19[MESH] |Female[MESH] |Heart Rate/physiology[MESH] |Humans[MESH] |Middle Aged[MESH]Management of COVID-19 in a durable left ventricular assist device rec(epmc).pdf DeepDyve Pubget Overpricing